NCT07637734Phase 3Recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

Study sponsor: Verrica Pharmaceuticals Inc. · VRCA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-05Estimated
Enrollment · participants300Estimated
Source updated2026-09-03Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Primary completion date changed

Before: Aug 2027. After: May 2027.

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source